Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from XBiotech ( (XBIT) ) is now available.
On October 2, 2025, XBiotech, Inc. entered into a new Executive Employment Agreement with John Simard, effective from October 1, 2025, to replace previous agreements. The agreement, approved by the Compensation Committee, formalizes Mr. Simard’s compensation trends and acknowledges his contributions and leadership, ensuring a smooth transition in case of his departure or retirement. Mr. Simard’s annual base salary is set at $1,250,000, with an annual base bonus of $4,530,442, subject to adjustments and committee discretion for additional compensation. The agreement also outlines severance terms and continued consulting roles post-retirement.
More about XBiotech
Average Trading Volume: 50,459
Technical Sentiment Signal: Sell
Current Market Cap: $80.49M
See more data about XBIT stock on TipRanks’ Stock Analysis page.